Shenzhen Chipscreen Biosciences Co., Ltd.

Shanghai Stock Exchange 688321.SS

Shenzhen Chipscreen Biosciences Co., Ltd. Price to Sales Ratio (P/S) on January 14, 2025: 13.23

Shenzhen Chipscreen Biosciences Co., Ltd. Price to Sales Ratio (P/S) is 13.23 on January 14, 2025, a -15.81% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Shenzhen Chipscreen Biosciences Co., Ltd. 52-week high Price to Sales Ratio (P/S) is 19.34 on November 12, 2024, which is 46.24% above the current Price to Sales Ratio (P/S).
Shenzhen Chipscreen Biosciences Co., Ltd. 52-week low Price to Sales Ratio (P/S) is 10.16 on February 05, 2024, which is -23.18% below the current Price to Sales Ratio (P/S).
Shenzhen Chipscreen Biosciences Co., Ltd. average Price to Sales Ratio (P/S) for the last 52 weeks is 14.91.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Shanghai Stock Exchange: 688321.SS

Shenzhen Chipscreen Biosciences Co., Ltd.

CEO	Dr. Xian-Ping Lu
IPO Date	Aug. 12, 2019
Location	China
Headquarters	Biology Incubator Building 2
Employees	1,057
Sector	Health Care
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials

Description

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.

Key trends

Past 5 years